Recombinant Mouse Antibody clone 7-17, which is specific to HCMV gB. Mab 7-17 was the only murine antibody with an IgG3 constant region which could mediate biological activity via cooperativity through Fc-Fc interactions.
Figure 1 Recognition of mutant ΔgB651 by AD-1-specific MAb 7-17.
Wild-type (wt) gB and mutant ΔgB651 were expressed in monkey kidney cells infected with recombinant vaccinia viruses. (A) Following labeling with [35S]Met/Cys, infected cell proteins were immune precipitated with the AD-1-specific MAb 7-17, the gB oligomer-specific antibody 27-39, or antibody 58-15, which is directed at an epitope located at the extreme carboxyl terminus of gB, and the precipitated proteins were analyzed by SDS-PAGE under reducing conditions. The migration of the 150-kDa gB precursor protein of gB and the 120-kDa precursor protein of ΔgB651 is indicated in the margin. The migration of the 55-kDa TM cleavage product of gB and the 30-kDa cleavage product of the ΔgB651 mutant are also indicated. Note that ΔgB651 was not precipitated by MAb 58-15. (B) Supernatant from the infected cells was centrifuged at 13,000 × g for 20 min and then precipitated with MAb 7-17. Precipitated proteins were analyzed by SDS-PAGE.
Britt, W. J., Jarvis, M. A., Drummond, D. D., & Mach, M. (2005). Antigenic domain 1 is required for oligomerization of human cytomegalovirus glycoprotein B. Journal of virology, 79(7), 4066-4079.
Figure 2 Oligomerization of ΔgB651.
Monkey kidney cells were infected with a recombinant vaccinia virus expressing ΔgB651 and pulse-labeled with [35S]Met/Cys for 10 min. The cultures were then washed extensively and either harvested immediately (time [T] = 0 min) or incubated in media for 120 min. Infected cell proteins from both cultures were centrifuged through a 5 to 30% sucrose gradient for 16 h. One-milliliter fractions were collected from the bottom of the gradient and precipitated with MAb 7-17. Precipitated proteins were analyzed by SDS-PAGE. Note the increased concentration of precipitated ΔgB651 in fraction 3 in the later chase interval, indicating multimerization. The top of the gradient is indicated.
Britt, W. J., Jarvis, M. A., Drummond, D. D., & Mach, M. (2005). Antigenic domain 1 is required for oligomerization of human cytomegalovirus glycoprotein B. Journal of virology, 79(7), 4066-4079.
Figure 3 Pulse-chase analysis of the ΔgB55.
The mutant ΔgB55 was expressed as a recombinant vaccinia virus, and infected monkey kidney cells were pulse-labeled for 2 min with [35S]Met/Cys and then chased in media for the indicated times. The infected cell proteins were precipitated with either MAb 58-15 or the AD-1-specific MAb 7-17, and the precipitated proteins were analyzed by SDS-PAGE under nonreducing conditions. The migration of the forms of ΔgB55 is indicated in the left margin.
Britt, W. J., Jarvis, M. A., Drummond, D. D., & Mach, M. (2005). Antigenic domain 1 is required for oligomerization of human cytomegalovirus glycoprotein B. Journal of virology, 79(7), 4066-4079.
Figure 4 Analysis of gB cysteine mutants.
Image analysis of gB mutants. gB cysteine mutants were generated and transiently expressed in COS-7 cells grown on glass coverslips. Following fixation in 3% paraformaldehyde, the cells were permeabilized and stained with the AD-1-specific MAb 7-17 or the C-terminal specific MAb 58-15 and developed with FITC-conjugated goat anti-mouse IgG3 or Texas red-conjugated goat anti-mouse IgG2b, respectively. Merged images reveal colocalization of signals resulting in a yellow signal. Wt, wild type.
Britt, W. J., Jarvis, M. A., Drummond, D. D., & Mach, M. (2005). Antigenic domain 1 is required for oligomerization of human cytomegalovirus glycoprotein B. Journal of virology, 79(7), 4066-4079.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-443-S(P) | Recombinant Anti-HCMV GB Antibody scFv Fragment | WB, Neut, FuncS | scFv |
MHH-443-S(P) | Recombinant Human Anti-HCMV GB Antibody scFv Fragment | WB, FC, FuncS | scFv |
HPAB-0639-CN-S(P) | Recombinant Human Anti-HCMV gB Antibody scFv Fragment (2F10) | ELISA, Neut | Human scFv |
FAMAB-0142JF-S(P) | Human Anti-HCMV gB Recombinant Antibody (clone SM10); scFv Fragment | WB, ELISA, FuncS | Human scFv |
FAMAB-0145JF-S(P) | Human Anti-HCMV gB Recombinant Antibody (clone SM1-6); scFv Fragment | WB, ELISA, FuncS | Human scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
MHH-443 | Recombinant Human Anti-HCMV GB Antibody | FC, Neut, Funcs | IgG |
HPAB-0639-CN | Recombinant Human Anti-HCMV gB Antibody (2F10) | ELISA, Neut | Human IgG |
HPAB-0640-CN | Recombinant Human Anti-HCMV gB Antibody (2M16) | ELISA, Neut | Human IgG |
HPAB-0641-CN | Recombinant Human Anti-HCMV gB Antibody (2N9) | ELISA, Neut | Human IgG |
HPAB-0642-CN | Recombinant Human Anti-HCMV gB Antibody (4P12) | ELISA, Neut | Human IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
MRO-1032LC | Anti-HCMV gB Recombinant Antibody (TI-23) | ELISA | Humanized antibody |
MRO-1032LC-S(P) | Anti-HCMV gB Recombinant Antibody scFv Fragment (TI-23) | ELISA | Humanized antibody |
MRO-1032LC-F(E) | Anti-HCMV gB Recombinant Antibody Fab Fragment (TI-23) | ELISA | Humanized antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
MRO-1033LC-F(E) | Anti-HCMV gB Recombinant Antibody Fab Fragment (C1) | ELISA | Human antibody |
MRO-1034LC-F(E) | Anti-HCMV gB Recombinant Antibody Fab Fragment (C3) | ELISA | Human antibody |
MRO-1035LC-F(E) | Anti-HCMV gB Recombinant Antibody Fab Fragment (C4) | ELISA | Human antibody |
MRO-1036LC-F(E) | Anti-HCMV gB Recombinant Antibody Fab Fragment (C7) | ELISA | Human antibody |
MRO-1037LC-F(E) | Anti-HCMV gB Recombinant Antibody Fab Fragment (C23) | ELISA | Human antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
EPAF-1438LC | Recombinant Human Anti-HCMV gB Antibody (MAb C23) | WB | IgG1 |
EPAF-1497LC | Recombinant Mouse Anti-HCMV gB Antibody (CH28-2) | ELISA |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-0639-CN-F(E) | Recombinant Human Anti-HCMV gB Antibody Fab Fragment (2F10) | ELISA, Neut | Human Fab |
HPAB-0640-CN-F(E) | Recombinant Human Anti-HCMV gB Antibody Fab Fragment (2M16) | ELISA, Neut | Human Fab |
HPAB-0641-CN-F(E) | Recombinant Human Anti-HCMV gB Antibody Fab Fragment (2N9) | ELISA, Neut | Human Fab |
HPAB-0642-CN-F(E) | Recombinant Human Anti-HCMV gB Antibody Fab Fragment (4P12) | ELISA, Neut | Human Fab |
HPAB-0643-CN-F(E) | Recombinant Human Anti-HCMV gB Antibody Fab Fragment (5P9) | ELISA, Neut | Human Fab |
There are currently no Customer reviews or questions for FAMAB-0173CQ. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.